This brand name is authorized in Nigeria.
The drug PRIGATEX contains one active pharmaceutical ingredient (API):
1
|
UNII
55JG375S6M - PREGABALIN
|
|
Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101165 | Capsule | Prigatex Capsules 150 mg CAP 150 mg 10 x 15's (in Alu-PVC blisters) | Capsule Caramel /pink colored hard gelatin capsule having size “2” containing white powder | 30/01/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N02BF02 | Pregabalin | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-101165 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.